JPRN-UMIN000018085已完成未知
The study of effects of Canagliflozin ON T2DM patients' glycemic value Reduction and On Lowering dosage of insulin therapy - CONTROL Study
niversity of Occupational and Environmental Health0 个研究点目标入组 58 人开始时间: 2015年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •For those who fall into any of the following criteria are excluded from the study: 1. Patients who use SGLT2, GLP-1, SU, or glinide within last 12 weeks just before giving their consent 2. Patients who are dehydrated 3. Patients who are on emulgent 4. Patients who are hospitalized as a result of sick day 5. Patients with serious infection or injury, or perioperative patients 6. Patients with a history of myocardial infarction, angina, stroke, or cerebral infarction 7. Patients with moderate renal dysfunction (eGFR<45mL/min/1.73m2) 8. Patients with severe liver functional impairment (AST>=100 IU/L) 9. Patients with moderate to severe heart failure as class 3 or worse based on the New York Heart Association (NYHA) Functional Classification 10. Patients with urinary tract infection, or genital infection 11. Patients with a malignant tumor or have a history of malignant tumor (exceptions: those are not on medication for malignant tumor, and have no recurrence of the disease so far and without recurrence risks during this study are allowed to participate) 12. If canagliflozin is prohibited to use 13. Patients with other conditions that are judged by a physician to be inappropriate to this study
研究者
相似试验
已完成
不适用
Effect of canagliflozin in type 2 diabetic patients with microalbuminuria in Japanese populatioType 2 diabetes with microalbuminuriaJPRN-UMIN000029905Okayama University Hospital300
进行中（未招募）
不适用
Effect of canagliflozin in type 2 diabetic patients with microalbuminuria in Japanese populatioType 2 diabetes with microalbuminuriaJPRN-jRCTs061180047Miyamoto Satoshi110
已完成
不适用
Effect of SGLT2 inhibitor, canagliflozin, for the size of lipid particlesType 2 diabetesJPRN-UMIN000020027Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy30
招募中
不适用
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
已完成
不适用
Influence of SGLT2-inhibitor (Canagliflozin) in patients with DM who underwent cardiac surgerypatients with diabetes mellitus underwent cardiac surgeryJPRN-UMIN000021239Sekino Hospital30